prof. MUDr. Daniel Pella, PhD.

	Email:	daniel.pella@upjs.sk
	Homepage:	https://www.upjs.sk/LF/zamestnanec/daniel.pella
	Faculty:	LF UPJŠ - Pavol Jozef Šafárik University in Košice Faculty of Medicine
	Department:	2. KK - 2nd Department of Cardiology
	Office:
	Phone:
	ORCID ID:	0000-0001-9999-6271

Prof. MUDr. Daniel Pella , PhD. is the head of 2nd Department of Cardiology UPJŠ FM and ESICD a.s. and the general director of the SLOVACRIN . For two terms he served as Vice-Dean for International Relations and Studies in the English Language, where he significantly influenced the internationalization of UPJŠ Faculty of Medicine and since 2014 to 2022 had headed it as Dean faculty of Medicine UPJŠ in Košice. In 2023 he was elected Rector UPJŠ in Košice. The dominant feature of his professional focus is non-interventional cardiology, especially the prevention of cardiovascular diseases. He has been working as a university teacher for almost 30 years, but at the same time he is intensively involved in international clinical scientific research, the aim of which is to introduce new drugs into everyday medical practice. He was the president of the International College of Nutrition and the Slovak Atherosclerosis Association. He is a member of the scientific councils of all Slovak medical faculties, a member of the Council for the Support of Biomedical Research Development of the Ministry of Health of the Slovak Republic and the Scientific Council of the Ministry of Health of the Slovak Republic. He is a member of the editorial boards of several Slovak and foreign magazines. For several years he has been involved in the creation of recommendations of the European Society of Cardiology (the only representative from the Slovak Republic) for the prevention and treatment of cardiovascular diseases. Participates in the solution of several scientific projects basic and applied research. He is the author or co-author of more than 200 original scientific papers (of which more than 100 CC / WoS / Scopus) published mainly in foreign journals, which were cited more than 3,900 times in WoS / Scopus citation indexes.

Higher education and further qualification growth

First degree of higher education:

Pavol Jozef Šafárik University in Kosice, Faculty of Medicine, 1980-1986, General Medicine

Second degree of higher education:

Pavol Jozef Šafárik University in Košice, Faculty of Medicine, 1986, General Medicine

Third degree of higher education:

Pavol Jozef Šafárik University in Košice, Faculty of Medicine, 2000, field of study: General Medicine, study program: Internal Diseases

Associate professor:

Pavol Jozef Šafárik University in Košice, Faculty of Medicine, 2003, field of study: General Medicine, study program: Internal Diseases

Professor:

Charles University in Prague, 1st Faculty of Medicine, Czech Republic, 2007, field of study: General Medicine, study program: Internal Diseases

Research /art/ teacher profile

Display details

Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
Study programme: General Medicine - Person responsible for the study programme, study field: General Medicine, joined I. and II. degree
Study programme: Internal Diseases - Person responsible for the profile subject, study field: General Medicine, III. degree
Profile courses
Clinical physiology of internal diseases - Internal Disease, III. degree
Internal Medicine 6 - General Medicine, joined I. and. II. degree
Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
Name of the field of habilitation procedure and inaugural procedure: Internal Diseases, study field to which it is assigned: General Medicine
Selected publications
ADC – RIDKER, P.M. - EVERETT, B.M. - THUREN, T. - MACFADYEN, J.G. - PELLA, Daniel et al: Antiinflammatory therapy with canakinumab for atherosclerotic disease; In: New England Journal of Medicine. - ISSN 0028-4793. - Vol. 377, no. 12 (2017), s. 1119-1131. CCC; 2017 CCC IF=79,260; 2017 Q1 (Medicine, General & Internal) SCIE; cited 975x
ADC – BANACH, Maciej - PATTI, Angelo Maria - GIGLIO, Rosaria Vincenza - CICERO, Arrigo F.G. - ATANASOV, Atanas G. - PELLA, Daniel: The Role of Nutraceuticals in Statin Intolerant Patients; In: Journal of the American College of Cardiology : slovenské vydanie. - ISSN 1335-8278. - Roč. 72, č. 1 (2018), s. 96-118. 10.1016/j.jacc.2018.04.040 DOI; CCC; SCOPUS; WOS CC; 2018 CCC IF=18,639; 2018 Q1 (Cardiac & Cardiovascular Systems) SCIE; cited 65x
ADC – CICERO, Arrigo, F.G. - COLLETTI, Alessandro - BAJRAKTARI, Gani - DESCAMPS, Oliver - DJURIC, Dragan M. - PELLA, Daniel: Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel; In: Nutrition Review. - ISSN 0029-6643. - Vol. 75, no. 9 (2017), s. 731-767. CCC; 2017 CCC; cited 64x
ADC – FOGACCI, Federica - BANACH, Maciej - MIKHAILIDIS, Dimitri P. - BRUCKNER, Eric - TOTH, Peter P. - WATTS, Gerald F. - REINER, Željko - MANCINI, John - RIZZO, Manfredi - MITCHENKO, Olena - PELLA, Daniel - FRAS, Zlatko - SAHEBKAR, Amirhossein - VRABLÍK, Michal (6.666%) - CICERO, Arrigo F.G.: Safety of red yeast rice supplementation: A systematic review and meta-analysis of randomized controlled trials; In: Pharmacological research. - ISSN 1043-6618. - č. 143 (2019), s. 1-16. 10.1016/j.phrs.2019.02.028 DOI; CCC; SCOPUS; WOS CC; 2019 CCC IF=5,893; 2019 Q1 (Pharmacology & Pharmacy) SCIE; cited 20x
ADC – Daniel PELLA, Stefan TOTH, Jan PARALIC, Jozef GONSORCIK, Jan FEDACKO, Peter JARCUSKA, Dominik PELLA, Zuzana PELLA, Frantisek SABOL, Monika JANKAJOVA, Gabriel VALOCIK, Alina PUTRYA, Andrea KIRSCHOVA, Lukas PLACHY, Miroslava RABAJDOVA, Mikulas HUNAVY, Bibiana KAFKOVA, Ivan DOCI, Silvia TIMKOVA, Mariana DVOROZNAKOVA, Frantisek BABIC, Peter BUTKA, Lucia DIMUNOVA, Maria MAREKOVA, Zuzana PARALICOVA, Jaroslav MAJERNIK, Jan LUCZY, Jakub JANOSIK, Martin KMEC: The possible role of machine learning in detection of increased cardiovascular risk patients – KSC MR Study (design); In: Arch Med Sci 2022;18(4); DOI: https://doi.org/10.5114/aoms.2020.99156; CCC; SCOPUS; WOS CC; IF=3,318; 2022 Q1 (Medicine)
Selected projects
AKARDIO COVID 19: Analysis of cardiovascular and immunological response of patients after overcoming COVID-19 with a focus on research of new diagnostic markers and therapeutic agents; guarantor of the main activity
APVV 17-0550: Determinants of increased cardiovascular risk and their prognostic significance analyzed by machine learning in the diagnosis of high-risk individuals; responsible solver
OPENMED-ITMS2014+: 313011V455: Open scientific community for modern interdisciplinary research in medicine; 2014 - 2020; responsible for the activity
International mobilities and visits
study stay, Lisbon, Portugal, 2008, Novel trends in hypertension therapy
Cleveland Heart Clinic, Cleveland, USA, 2005, Post myocardial infarction patients - management and treatment - clinical research programm
Cardiologic Clinic of the prof. Luigi de Ambroggi, Ospedale di San Donato Milanese, 1995, Surface ECG mapping
Complutense University, Madrid, Spain, 1994, Dyslipidemia management in post MI patients
Organisational activities
dean - UPJŠ in Košice, Faculty of Medicine, 2014-2022
chairman of Board of study program - General Medicine - UPJŠ in Košice, Faculty of Medicine, since 2021
member of the Commission for the Defense of Dissertations in Internal Diseases - UPJŠ in Košice, Faculty of Medicine, since 2014
chairman of Scientific board - UPJŠ in Košice, Faculty of Medicine, since 2014
member of Scientific board - UPJŠ in Košice, since 2014

Additional information

Awards

2022: Awards of Košice on the occasion of his life jubilee, for scientific and pedagogical activities in the preparation of future doctors and PhD. students
1999: International Award of the Millenium for the lecture "Secondary prevention of atherosclerosis by combined treatment with pravastatin and sulodexide" in New Delhi
2004:prize for the best original scientific work published in a journal registered in Current Contents in 2002, 2003 awarded by the dean of the Faculty of Medicine UPJŠ in Košice
2006: award from the International College of Cardiology for significant contribution to the development of society
2007: International College of Clinical Nutrition award given by the president of the company prof. Ozimekom from Canada
2018: Slovak Literary Fund Award for scientific and professional literature for exceptional scientific response to one work

Projects

APVV-17-0550: Determinants of increased cardiovascular risk and their prognostic significance analyzed using machine learning in the diagnosis of high-risk individuals
OPENMED: Open scientific community for modern interdisciplinary research in medicine, ITMS2014+:313011V455; Activity: 313V45500005-H5 Cardiovascular diseases (NV95)
AKARDIO COVID19: Analysis of the cardiovascular and immunological response of patients after overcoming COVID-19 with a focus on the research of new diagnostic markers and therapeutic agents, ITMS code: 313011AUB1; Activity: 313AUB100001 Research of new diagnostic markers and therapeutic agents with the diagnosis of COVID-19
VEGA1337/2004: Are the pleiotropic effects of statins only positive? - responsible solver
1335/2004: The effect of omega-3 fatty acids on the prevention of cardiovascular events; International College of Cardiology, Heart Research Centre Moradabad - co-solver
HEPAMETA - ITMS: 26220120058 : Cross-sectional epidemiological study mapping the prevalence of hepatitis B and C and metabolic syndrome in the population of Slovak Roma; project from the EU SF - deputy project leader
PROBIO - ITMS: 26220220104: Probiotic microorganisms and bioactive substances of natural origin for a healthier population of Slovakia; project from the EU SF project - co-solver
National Coordinator of International Multicenter Clinical Studies:
2000-CL3-16257-021: Evaluation of the tolerance and safety of oral chronic administration of ivabradine in patients with stable effort angina pectoris - co-solver
Du-176b PRT018: A phase 2, randomized, parallel group, multi-center, multi-national study for the evaluation of safety of four sixed dose regimens of DU-176b in subjects with non-valvular atrial fibrillation - co-solver
National coordinator of multicenter research projects under the auspices of the Slovak Society of Cardiology:
PROGRESSIVE: 2006 – focused on pharmacotherapy of arterial hypertension
DELFÍN: 2007 – focused on pharmacotherapy of arterial hypertension
MYODEA: preventive program developed by the International College of Cardiology with a focus on the prevention of cardiovascular diseases - co-author

International collaboration

International College of Cardiology
International College of Clinical Nutrition
G.P. Littarru, Ancona, Taliansko
S.A. Mortensen, Kodaň, Dánsko
R.B. Singh, Moradabad, India
E. Berry, Jerusalem, Izrael
B. Tomlinson, Hong Kong, Hong Kong

Further information

Taught courses and supervised study programmes